Information on the Target
360 Capital has invested in Oxyle, a pioneering company dedicated to providing innovative solutions to the growing problem of PFAS (Per- and Polyfluoroalkyl Substances) contamination. Unlike conventional methods that merely capture PFAS from wastewater and drinking water, Oxyle's technology is capable of destroying these harmful substances with a remarkable efficiency of over 99%. This capability not only addresses the immediate contamination but also avoids the need for additional waste disposal processes.
Founded as a response to the urgent need for effective PFAS remediation, Oxyle stands out in the climate tech sector for its breakthrough approach. Its technology is designed to meet the stringent regulatory demands emerging globally while being cost-effective and energy-efficient, operating at energy inputs significantly lower than competitors.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The issue of PFAS contamination has reached critical levels worldwide, with a particularly acute crisis in the United States and European Union. In the U.S., the PFAS water treatment market is expected to grow progressi
Similar Deals
360 Capital
invested in
Oxyle
in
in a Other VC deal